| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000059487A3 Flupirtine in the treatment of fibromyalgia and related conditions |
| 08/16/2001 | WO2000056356B1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 08/16/2001 | US20010014696 Therapeutic compositions (II) |
| 08/16/2001 | US20010014454 Novel metal complexes |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123922A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/16/2001 | EP1123094A1 Therapeutic compositions (ii) |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/14/2001 | US6274757 Neuromuscular relaxants |
| 08/14/2001 | US6274623 Neuromuscular relaxants |
| 08/14/2001 | US6274603 Administering probucol or an analog to treat alzheimer's disease |
| 08/14/2001 | US6274594 Isoquinoline derivatives and their therapeutical use |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056576A1 Transdermal therapeutic system for the administration of zaleplon |
| 08/09/2001 | WO2001019966A3 Isolation of muscle-derived stem cells and uses therefor |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000076452A3 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 08/09/2001 | WO2000075144A8 Peroxynitrite decomposition catalysts and methods of use thereof |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | US20010012834 Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| 08/09/2001 | US20010012833 Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B |
| 08/09/2001 | DE10004790A1 Plaster-form transdermal therapeutic system containing zaleplon, especially for use as hypnotic agent, providing safe and controlled drug delivery |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399058A1 Targeting peptides |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | CA2398215A1 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/08/2001 | EP1122243A1 Novel imidazoles with anti-inflammatory activity |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121349A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1306841A Preparation of bone-strengthening musk plaster |
| 08/07/2001 | US6271262 Metalloproteinase inhibitors |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/02/2001 | WO2001055692A2 Neurosteroids as markers for alzheimer's disease |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055219A2 scsCNTFR/NNT-1 FUSION PROTEIN |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055176A2 Methods for inhibiting smooth muscle cell proliferation |
| 08/02/2001 | WO2001055172A2 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN |
| 08/02/2001 | WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | WO2001054699A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001054648A2 Treatment of disorders affecting vigilance related to myopathies |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011103 Pure isomers |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398358A1 The neurosteroid dhea as a marker for neuropathologies |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2395730A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | CA2394525A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | EP0719268B1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306525A Carboxylic acid of aza-heterocyclic compounds contg. multiple hetero-atoms or its electronic isosteric object |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state |
| 07/31/2001 | US6268473 Amino acid sequences; muscle relaxants; treating benign essential blepharospasm and other forms of focal dystonia; antiwrinkle agents |
| 07/31/2001 | US6268398 Aromatic guanidine derivatives |
| 07/26/2001 | WO2001053350A1 Myostatin and mimetics thereof |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001052903A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2000047238A9 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | CA2397492A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1117805A2 Modified tgf-beta superfamily proteins |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117426A2 Akt compositions for enhancing survival of cells |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP0739206B1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 07/25/2001 | CN1304936A Quinoline-4-radical derivative II |
| 07/25/2001 | CN1304743A Medicine for treating injury |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265434 Antiinflammatory agents |